首页> 外文OA文献 >Development of a Luciferase-Based Assay to Screen for Gametocyte-Specific Antimalarial Drugs
【2h】

Development of a Luciferase-Based Assay to Screen for Gametocyte-Specific Antimalarial Drugs

机译:基于荧光素酶的检测方法的开发,以筛选配子体特异性抗疟药

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

For centuries, Malaria has continued to be one of the most deadly infectious diseases in the world. Almost all of the current antimalarial drugs target the asexual blood stages of the Plasmodium parasite responsible for the clinical pathology of malaria, but nearly all have no activity against the mature gametocyte or sexual stage that is responsible for the transmission of the parasite through the mosquito vector. Renewed interest in global eradication of malaria has turned some of the focus on blocking transmission. We have developed transgenic Plasmodium berghei that expresses luciferase under the control of gametocyte-specific promoters. Pb920Lux is a transgenic parasite that expresses luciferase in both male and female gametocytes, while Pb610Lux is a transgenic parasite that expresses luciferase in the male gametocyte. Immunofluorescence assay (IFA) shows luciferase is expressed in some parasites and in accordance with a previous study, suggest these may be gametocytes. These transgenic parasites were then used in a luciferase-based drug assay. Seven known antimalarial drugs were used to confirm the validity of the assay. Four of the known drugs had gametocidal activity, while three of the drugs have no gametocidal activity. We first created a dose response using the Pb920Lux and Pb610Lux along with PbGFPLuxcon as our control. From there we calculate the IC50 values of these drugs and compared them to the IC50 values calculated using PbGFPLuxcon (control). As expected, the transgenic parasites showed significant gametocidal activity in the four known drugs and no significant activity in the three non-gametocidal drugs. We confirmed this finding by calculating the percentage of parasites and gametocyte by light microscope and compared these to our findings with the luciferase-based assay. Next we analyzed four unknown drugs and found that they contain no gametocidal activity. The public health importance of developing a luciferase-based assay specific for gametocytes is to provide a simple and efficient method of detecting gametocidal drugs in order to prevent the transmission of malaria.
机译:几个世纪以来,疟疾一直是世界上最致命的传染病之一。几乎所有当前的抗疟药都针对负责疟疾临床病理的疟原虫寄生虫的无性血液阶段,但几乎没有针对成熟的配子体或性阶段的活性,而成熟的配子体或性阶段负责寄生虫通过蚊子媒介的传播。对全球消灭疟疾的重新兴趣使部分注意力转向了阻止传播。我们已经开发了在配子体特异性启动子控制下表达荧光素酶的转基因伯氏疟原虫。 Pb920Lux是一种在雄性和雌性配子体细胞中均表达萤光素酶的转基因寄生虫,而Pb610Lux是一种在雄性配子体细胞中表达萤光素酶的转基因寄生虫。免疫荧光测定(IFA)显示萤光素酶在某些寄生虫中表达,并且根据先前的研究,表明这些可能是配子细胞。然后将这些转基因寄生虫用于基于萤光素酶的药物测定中。使用七种已知的抗疟疾药物来确认测定的有效性。已知的四种药物具有杀虫活性,而三种药物则无杀虫活性。我们首先使用Pb920Lux和Pb610Lux以及PbGFPLuxcon作为对照来创建剂量反应。从那里我们计算这些药物的IC50值,并将它们与使用PbGFPLuxcon(对照)计算的IC50值进行比较。如预期的那样,转基因寄生虫在四种已知药物中显示出显着的杀螨活性,而在三种非杀真菌剂中均未显示出显着活性。我们通过光学显微镜计算寄生虫和配子体的百分比来证实这一发现,并将其与基于荧光素酶的检测结果进行比较。接下来,我们分析了四种未知药物,发现它们没有杀虫活性。开发针对配子细胞的基于萤光素酶的检测方法对公共卫生的重要性在于,提供一种简单有效的方法来检测杀螨药,以防止疟疾传播。

著录项

  • 作者

    Fields Becita;

  • 作者单位
  • 年度 2012
  • 总页数
  • 原文格式 PDF
  • 正文语种 en
  • 中图分类

相似文献

  • 外文文献
  • 中文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号